|
US7157555B1
(en)
*
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
|
US7829084B2
(en)
*
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
BR0317538A
(pt)
|
2002-12-20 |
2005-11-29 |
Amgen Inc |
Agente ligante, sequência de polinucleotìdeo, vetor de expressão, célula hospedeira, composição farmacêutica, e, métodos de inibir a atividade de miostatina, de aumentar a massa muscular magra e a razão de massa muscular magra para gordura, de tratar uma doença de emaciação muscular e um distúrbio metabólico relacionado com miostatina em um indivìduo, de detectar e medir miostatina em uma amostra, e, de diagnosticar um distúrbio relacionado com miostatina em um indivìduo
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
PL2298347T3
(pl)
|
2003-05-06 |
2016-03-31 |
Bioverativ Therapeutics Inc |
Białka chimeryczne czynnika krzepnięcia do leczenia zaburzenia hemostazy
|
|
US7850970B2
(en)
|
2003-08-26 |
2010-12-14 |
The Regents Of The University Of Colorado |
Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
|
|
KR101135244B1
(ko)
*
|
2007-11-29 |
2012-04-24 |
한미사이언스 주식회사 |
인슐린 분비 펩타이드 결합체를 포함하는 비만 관련질환 치료용 조성물
|
|
ES2383300T3
(es)
*
|
2003-11-13 |
2012-06-20 |
Hanmi Holdings Co., Ltd |
Fragmento Fc de IgG para un vehículo de fármacos y procedimiento para su preparación
|
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
|
US8263084B2
(en)
*
|
2003-11-13 |
2012-09-11 |
Hanmi Science Co., Ltd |
Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
|
|
CA2559228C
(en)
|
2004-04-21 |
2016-06-21 |
Enobia Pharma Inc. |
Bone delivery conjugates and method of using same to target proteins to bone
|
|
US20070081984A1
(en)
|
2005-10-11 |
2007-04-12 |
Shunji Tomatsu |
Compositions and methods for treating hypophosphatasia
|
|
US8143380B2
(en)
*
|
2004-07-08 |
2012-03-27 |
Amgen Inc. |
Therapeutic peptides
|
|
WO2006036834A2
(en)
|
2004-09-24 |
2006-04-06 |
Amgen Inc. |
MODIFIED Fc MOLECULES
|
|
KR100594607B1
(ko)
*
|
2004-11-03 |
2006-06-30 |
재단법인서울대학교산학협력재단 |
신규한 경구투여용 재조합 인간 성장호르몬 분비미생물제제 및 그 제조방법
|
|
WO2006071877A2
(en)
*
|
2004-12-27 |
2006-07-06 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally deliverable and anti-toxin antibodies and methods for making and using them
|
|
JP2008536477A
(ja)
*
|
2005-02-14 |
2008-09-11 |
アポロ ライフ サイエンシズ リミテッド |
分子およびそのキメラ分子
|
|
KR100754667B1
(ko)
*
|
2005-04-08 |
2007-09-03 |
한미약품 주식회사 |
비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물
|
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
RU2423381C2
(ru)
*
|
2005-07-25 |
2011-07-10 |
Трабьон Фармасьютикалз, Инк. |
Снижение количества в-клеток с использованием cd37-специфических и cd20-специфических связывающих молекул
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
RU2428430C2
(ru)
*
|
2005-08-16 |
2011-09-10 |
Ханми Холдингс Ко., Лтд. |
СПОСОБ МАССОВОГО ПРОИЗВОДСТВА ОБЛАСТИ Fc ИММУНОГЛОБУЛИНА С УДАЛЕННЫМИ НАЧАЛЬНЫМИ МЕТИОНИНОВЫМИ ОСТАТКАМИ
|
|
KR100824505B1
(ko)
*
|
2005-08-16 |
2008-04-22 |
한미약품 주식회사 |
개시 메티오닌 잔기가 제거된 면역글로불린 Ｆｃ 영역의대량 생산방법
|
|
CN101534865A
(zh)
*
|
2005-10-19 |
2009-09-16 |
Ibc药品公司 |
生物活性装配体的制备方法及其用途
|
|
US20070122408A1
(en)
*
|
2005-10-20 |
2007-05-31 |
The Scripps Research Institute |
Fc Labeling for Immunostaining and Immunotargeting
|
|
TW200732350A
(en)
*
|
2005-10-21 |
2007-09-01 |
Amgen Inc |
Methods for generating monovalent IgG
|
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
|
CA2631184A1
(en)
|
2005-11-28 |
2007-05-31 |
Genmab A/S |
Recombinant monovalent antibodies and methods for production thereof
|
|
WO2007067616A2
(en)
*
|
2005-12-06 |
2007-06-14 |
Amgen Inc |
Uses of myostatin antagonists
|
|
CN101002945B
(zh)
|
2006-01-20 |
2012-09-05 |
清华大学 |
一种用于肿瘤治疗的新型复合物
|
|
CN100475270C
(zh)
|
2006-01-20 |
2009-04-08 |
清华大学 |
一种治疗肿瘤的药物及其应用
|
|
NZ573646A
(en)
*
|
2006-06-12 |
2012-04-27 |
Wyeth Llc |
Single-chain multivalent binding proteins with effector function
|
|
SI2061803T2
(sl)
|
2006-08-28 |
2023-01-31 |
Ares Trading S.A. |
Postopek za čiščenje proteinov, ki vsebujejo FC
|
|
US20140147441A1
(en)
*
|
2006-09-12 |
2014-05-29 |
The General Hospital Corporation |
Compositions containing alpha-1-antitrypsin and methods for use
|
|
PE20081140A1
(es)
|
2006-10-25 |
2008-09-22 |
Amgen Inc |
Agentes terapeuticos a base de peptidos derivados de toxinas
|
|
US20080181903A1
(en)
*
|
2006-12-21 |
2008-07-31 |
Pdl Biopharma, Inc. |
Conjugate of natriuretic peptide and antibody constant region
|
|
JP2008169195A
(ja)
*
|
2007-01-05 |
2008-07-24 |
Hanmi Pharmaceutical Co Ltd |
キャリア物質を用いたインスリン分泌ペプチド薬物結合体
|
|
CN101219219B
(zh)
|
2007-01-10 |
2013-02-13 |
北京普罗吉生物科技发展有限公司 |
包含血管抑素或其片段的复合物、其制备方法及应用
|
|
US20080238882A1
(en)
*
|
2007-02-21 |
2008-10-02 |
Ramesh Sivarajan |
Symmetric touch screen system with carbon nanotube-based transparent conductive electrode pairs
|
|
US7947646B2
(en)
|
2007-03-06 |
2011-05-24 |
Amgen Inc. |
Variant activin receptor polypeptides
|
|
US8501678B2
(en)
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
|
EP2162540A2
(en)
|
2007-05-22 |
2010-03-17 |
Amgen Inc. |
Compositions and methods for producing bioactive fusion proteins
|
|
ES2623925T3
(es)
*
|
2007-05-30 |
2017-07-12 |
Postech Academy-Industry- Foundation |
Proteínas de fusión de inmunoglobulina
|
|
WO2008145140A2
(en)
|
2007-05-31 |
2008-12-04 |
Genmab A/S |
Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals
|
|
PL2185589T3
(pl)
|
2007-06-01 |
2016-09-30 |
|
Środki wiążące receptor regionu stałego Fc immunoglobuliny
|
|
US20100310561A1
(en)
*
|
2007-06-06 |
2010-12-09 |
Boehringer Ingelheim International Gmbh |
Natriuretic fusion proteins
|
|
JP2010531137A
(ja)
*
|
2007-06-12 |
2010-09-24 |
ワイス・エルエルシー |
抗ｃｄ２０治療用組成物および方法
|
|
JP2010532764A
(ja)
*
|
2007-07-06 |
2010-10-14 |
トゥルビオン・ファーマシューティカルズ・インコーポレーテッド |
Ｃ末端に配置された特異的結合性ドメインを有する結合性ペプチド
|
|
WO2009052415A1
(en)
*
|
2007-10-17 |
2009-04-23 |
The Regents Of The University Of California |
Peptide for the induction of immune tolerance as treatment for systemic lupus erythematosus
|
|
JP2011503000A
(ja)
*
|
2007-11-02 |
2011-01-27 |
セントコア・オーソ・バイオテツク・インコーポレーテツド |
半合成ＧＬＰ−１ペプチド−Ｆｃ融合コンストラクト、その方法及び使用
|
|
RU2531754C2
(ru)
*
|
2008-04-11 |
2014-10-27 |
ЭМЕРДЖЕНТ ПРОДАКТ ДИВЕЛОПМЕНТ СИЭТЛ,ЭлЭлСи,US |
Связывающееся с cd37 иммунотерапевтическое средство и его комбинация с бифункциональным химиотерапевтическим средством
|
|
MX2011000861A
(es)
*
|
2008-07-23 |
2011-06-21 |
Hanmi Holdings Co Ltd |
Un complejo polipeptidico que consiste en un polimero no-peptidil que posee tres terminaciones funcionales.
|
|
RU2457856C2
(ru)
*
|
2008-08-05 |
2012-08-10 |
Виктор Владимирович Чалов |
Композиция, обладающая противовирусным и антимикробным действием, для перорального применения
|
|
ES2574835T3
(es)
|
2008-08-07 |
2016-06-22 |
Ipsen Pharma S.A.S. |
Análogos del polipéptido insulinotrópico dependiente de glucosa
|
|
WO2010016940A2
(en)
*
|
2008-08-07 |
2010-02-11 |
Ipsen Pharma S.A.S. |
Analogues of glucose-dependent insulinotropic polypeptide
|
|
AU2009280021B2
(en)
*
|
2008-08-07 |
2012-10-04 |
Ipsen Pharma S.A.S. |
Analogues of glucose-dependent insulinotropic polypeptide (GIP) modified at N-terminal
|
|
EP2334335A1
(en)
*
|
2008-09-19 |
2011-06-22 |
Nektar Therapeutics |
Polymer conjugates of cd-np peptides
|
|
WO2010033240A2
(en)
|
2008-09-19 |
2010-03-25 |
Nektar Therapeutics |
Carbohydrate-based drug delivery polymers and conjugates thereof
|
|
AU2009308909A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Amgen Inc. |
Materials and methods relating to stem cell mobilization by multi-PEGylated granulocyte colony stimulating factor
|
|
JP5611222B2
(ja)
|
2008-11-26 |
2014-10-22 |
アムジエン・インコーポレーテツド |
アクチビンｉｉｂ受容体ポリペプチドの変異体及びその使用
|
|
WO2010065578A2
(en)
*
|
2008-12-04 |
2010-06-10 |
Leukosight Inc. |
POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (IgG) AND METHODS OF USING THE SAME
|
|
US20100158893A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Baxter International Inc. |
Systems and methods for obtaining immunoglobulin from blood
|
|
WO2010082804A2
(en)
*
|
2009-01-19 |
2010-07-22 |
Hanmi Pharm. Co., Ltd. |
Method for producing physiologically active protein or peptide using immunoglobulin fragment
|
|
WO2010096394A2
(en)
|
2009-02-17 |
2010-08-26 |
Redwood Biosciences, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
|
AU2010218139B2
(en)
|
2009-02-25 |
2012-11-01 |
Merck Sharp & Dohme Corp. |
Metabolic engineering of a galactose assimilation pathway in the glycoengineered yeast Pichia pastoris
|
|
JP5739865B2
(ja)
*
|
2009-03-24 |
2015-06-24 |
バイエル・ヘルスケア・エルエルシー |
第ｖｉｉｉ因子変異体および使用の方法
|
|
JP5727459B2
(ja)
*
|
2009-04-22 |
2015-06-03 |
アルテオゼン， インクＡｌｔｅｏｇｅｎ， Ｉｎｃ |
体内持続性を維持することにより体内半減期が増加したタンパク質またはペプチド融合体
|
|
EP2496262A2
(en)
*
|
2009-11-02 |
2012-09-12 |
Université de Genève |
Stabilized protein formulations and use thereof
|
|
WO2011075691A1
(en)
|
2009-12-18 |
2011-06-23 |
Exodos Life Sciences Limited Partnership |
Methods and compositions for stable liquid drug formulations
|
|
WO2011075185A1
(en)
|
2009-12-18 |
2011-06-23 |
Oligasis |
Targeted drug phosphorylcholine polymer conjugates
|
|
BR112012017982A2
(pt)
*
|
2010-01-19 |
2016-05-03 |
Hanmi Science Co Ltd |
formulações líquidas para conjugado de eritropoietina de longa ação
|
|
PT2525787T
(pt)
*
|
2010-01-19 |
2017-12-18 |
Hanmi Science Co Ltd |
Formulações líquidas para conjugado de g-csf de longa ação
|
|
WO2011093470A1
(ja)
*
|
2010-01-28 |
2011-08-04 |
協和発酵キリン株式会社 |
Bone morphogenetic protein receptor 1B(BMPR1B)細胞外ドメイン又はその変異体を含む蛋白質を含有する骨疾患治療用医薬組成物
|
|
RU2012140429A
(ru)
|
2010-02-24 |
2014-03-27 |
Мерк Шарп Энд Домэ Корп. |
Способ увеличения занятости участков n-ликозилирования на терапевтических гликопротеинах, продуцируемых в p pastoris
|
|
CA2789738C
(en)
*
|
2010-03-08 |
2021-03-09 |
Ge Healthcare Bio-Sciences Ab |
Immunoglobulin g fc region binding polypeptide
|
|
US9981017B2
(en)
|
2010-04-02 |
2018-05-29 |
Hanmi Science Co., Ltd. |
Insulin conjugate using an immunoglobulin fragment
|
|
AR081066A1
(es)
|
2010-04-02 |
2012-06-06 |
Hanmi Holdings Co Ltd |
Conjugado de insulina donde se usa un fragmento de inmunoglobulina
|
|
AR081755A1
(es)
*
|
2010-04-02 |
2012-10-17 |
Hanmi Holdings Co Ltd |
Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
|
|
AR080993A1
(es)
*
|
2010-04-02 |
2012-05-30 |
Hanmi Holdings Co Ltd |
Formulacion de accion prolongada de interferon beta donde se usa un fragmento de inmunoglobulina
|
|
BR112012027765A2
(pt)
|
2010-04-30 |
2019-09-24 |
Enobia Pharma Inc. |
métodos, composições e kits para tratamento de distúrbios de mineralização da matriz.
|
|
EP2571992B1
(en)
|
2010-05-21 |
2018-04-25 |
Merrimack Pharmaceuticals, Inc. |
Bi-specific fusion proteins
|
|
KR101330868B1
(ko)
*
|
2010-06-08 |
2013-11-18 |
한미사이언스 주식회사 |
면역글로불린 단편을 이용한 인슐린 유도체 약물 결합체
|
|
KR20120002129A
(ko)
*
|
2010-06-30 |
2012-01-05 |
한미홀딩스 주식회사 |
면역글로불린 단편을 이용한 제７인자（Ｆａｃｔｏｒ Ⅶａ）약물 결합체
|
|
KR101337797B1
(ko)
*
|
2010-07-14 |
2013-12-06 |
한미사이언스 주식회사 |
지속형 인간 성장 호르몬 결합체 액상 제제
|
|
KR101382593B1
(ko)
*
|
2010-07-21 |
2014-04-10 |
한미사이언스 주식회사 |
신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물
|
|
TWI542597B
(zh)
|
2010-07-28 |
2016-07-21 |
吉林尼克公司 |
產生依序多聚體化免疫球蛋白ｆｃ組合物之天然人類蛋白質片段之融合蛋白
|
|
WO2012053828A2
(ko)
*
|
2010-10-20 |
2012-04-26 |
주식회사 한독약품 |
인간 인터루킨-1 수용체 길항제-하이브리드 Ｆｃ 융합단백질
|
|
US8883134B2
(en)
|
2010-10-20 |
2014-11-11 |
Handok Pharmaceuticals, Inc. |
Human interleukin-1 receptor antagonist—hybrid Fc fusion protein
|
|
KR101303388B1
(ko)
*
|
2010-10-26 |
2013-09-03 |
한미사이언스 주식회사 |
지속형 인터페론 알파 결합체의 액상 제제
|
|
EP2465536A1
(en)
|
2010-12-14 |
2012-06-20 |
CSL Behring AG |
CD89 activation in therapy
|
|
SG191153A1
(en)
|
2010-12-23 |
2013-07-31 |
Hoffmann La Roche |
Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
|
|
WO2012088608A1
(en)
|
2010-12-27 |
2012-07-05 |
Enobia Canada Limited Partnership |
Compositions comprising natriuretic peptides and methods of use thereof
|
|
WO2012097333A2
(en)
|
2011-01-14 |
2012-07-19 |
Redwood Bioscience, Inc. |
Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
|
|
CN102309765B
(zh)
*
|
2011-02-28 |
2013-10-16 |
北京韩美药品有限公司 |
包含免疫球蛋白Fc片段作为载体的长效抗凝多肽及其制备方法
|
|
EP2694092B1
(en)
|
2011-04-08 |
2017-01-04 |
Amgen Inc. |
Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (gdf-15)
|
|
UA113626C2
(xx)
*
|
2011-06-02 |
2017-02-27 |
|
Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії
|
|
CN102807619B
(zh)
*
|
2011-06-03 |
2016-08-03 |
北京韩美药品有限公司 |
含有免疫球蛋白Fc片段和粒细胞-巨噬细胞集落刺激因子的复合物及其药物组合物
|
|
UA126465C2
(uk)
|
2011-06-10 |
2022-10-12 |
Ханмі Сайенс Ко., Лтд. |
Пептид, що має активність оксинтомодуліну, та фармацевтична композиція для лікування ожиріння, яка його містить
|
|
RU2607365C2
(ru)
*
|
2011-06-17 |
2017-01-10 |
Ханми Сайенс Ко., Лтд. |
Конъюгат, содержащий оксинтомодулин и фрагмент иммуноглобулина, и его применение
|
|
WO2012178102A2
(en)
*
|
2011-06-24 |
2012-12-27 |
The Regents Of The Unversity Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
AU2012275295B2
(en)
*
|
2011-06-28 |
2016-11-10 |
Inhibrx, Lp |
WAP domain fusion polypeptides and methods of use thereof
|
|
KR102231139B1
(ko)
*
|
2011-06-28 |
2021-03-24 |
인히브릭스, 인크. |
세르핀 융합 폴리펩타이드 및 이의 이용 방법
|
|
US10400029B2
(en)
|
2011-06-28 |
2019-09-03 |
Inhibrx, Lp |
Serpin fusion polypeptides and methods of use thereof
|
|
CN111053918A
(zh)
*
|
2011-09-05 |
2020-04-24 |
韩美科学株式会社 |
一种包含干扰素α-缀合物的抗癌用药物组合物
|
|
UY34347A
(es)
|
2011-09-26 |
2013-04-30 |
Novartis Ag |
Proteínas de función dual para tratar trastornos metabólicos
|
|
SG11201401205UA
(en)
|
2011-10-06 |
2014-05-29 |
Hanmi Science Co Ltd |
Blood coagulation factor ? and ?a derivatives, conjugates and complexes comprising the same, and use thereof
|
|
WO2013065343A1
(ja)
*
|
2011-10-31 |
2013-05-10 |
株式会社 島津製作所 |
非ペプチドヒンジ部含有フレキシブル抗体様分子
|
|
KR20130049671A
(ko)
|
2011-11-04 |
2013-05-14 |
한미사이언스 주식회사 |
생리활성 폴리펩타이드 결합체 제조 방법
|
|
HK1203384A1
(en)
|
2011-12-19 |
2015-12-11 |
Amgen Inc. |
Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
|
|
CN103172745A
(zh)
*
|
2011-12-21 |
2013-06-26 |
北京韩美药品有限公司 |
包含免疫球蛋白Fc片段的长效人内皮抑素
|
|
KR101895047B1
(ko)
|
2011-12-30 |
2018-09-06 |
한미사이언스 주식회사 |
면역글로불린 단편을 이용한 위치 특이적 글루카곤 유사 펩타이드-2 약물 결합체
|
|
KR102041412B1
(ko)
*
|
2011-12-30 |
2019-11-11 |
한미사이언스 주식회사 |
면역글로불린 Ｆｃ 단편 유도체
|
|
JP2015509091A
(ja)
|
2012-01-09 |
2015-03-26 |
ザ スクリプス リサーチ インスティテュート |
ヒト化抗体
|
|
CA2863224A1
(en)
|
2012-01-09 |
2013-07-18 |
The Scripps Research Institute |
Ultralong complementarity determining regions and uses thereof
|
|
CA2896951A1
(en)
|
2012-01-10 |
2013-07-18 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
EP3683228A3
(en)
|
2012-01-26 |
2020-07-29 |
Amgen Inc. |
Growth differentiation factor 15 (gdf-15) polypeptides
|
|
AR090281A1
(es)
|
2012-03-08 |
2014-10-29 |
Hanmi Science Co Ltd |
Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo
|
|
BR112014022240A2
(pt)
|
2012-03-09 |
2017-08-01 |
Csl Behring Ag |
composições compreendendo imunoglobulinas semelhantes à secretoras
|
|
EP2636684A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Prevention of infection
|
|
EP2636681A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Process for enriching IgA
|
|
US10064951B2
(en)
*
|
2012-03-30 |
2018-09-04 |
Hanmi Science Co., Ltd. |
Liquid formulation of highly concentrated long-acting human growth hormone conjugate
|
|
CA2871468C
(en)
*
|
2012-04-23 |
2021-09-21 |
Nrl Pharma, Inc. |
Lactoferrin fusion protein and method for preparation thereof
|
|
US10052366B2
(en)
|
2012-05-21 |
2018-08-21 |
Alexion Pharmaceuticsl, Inc. |
Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
|
|
EP2859017B1
(en)
|
2012-06-08 |
2019-02-20 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
WO2014004639A1
(en)
|
2012-06-26 |
2014-01-03 |
Sutro Biopharma, Inc. |
Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
|
|
KR20150030744A
(ko)
|
2012-06-27 |
2015-03-20 |
에프. 호프만-라 로슈 아게 |
표적에 특이적으로 결합하는 하나 이상의 결합 단위를 포함하는 항체 Ｆｃ－영역 접합체의 제조 방법 및 그의 용도
|
|
RU2639287C2
(ru)
|
2012-06-27 |
2017-12-20 |
Ф. Хоффманн-Ля Рош Аг |
Способ отбора и получения высокоселективных и мультиспецифичных нацеливающих групп с заданными свойствами, включающих по меньшей мере две различные связывающие группировки, и их применения
|
|
AR092862A1
(es)
|
2012-07-25 |
2015-05-06 |
Hanmi Pharm Ind Co Ltd |
Formulacion liquida de insulina de accion prolongada y un peptido insulinotropico y metodo de preparacion
|
|
AR094821A1
(es)
|
2012-07-25 |
2015-09-02 |
Hanmi Pharm Ind Co Ltd |
Formulación líquida de un conjugado de péptido insulinotrópico de acción prolongada
|
|
AR091902A1
(es)
|
2012-07-25 |
2015-03-11 |
Hanmi Pharm Ind Co Ltd |
Formulacion liquida de un conjugado de insulina de accion prolongada
|
|
US10441665B2
(en)
|
2012-07-25 |
2019-10-15 |
Hanmi Pharm. Co., Ltd. |
Liquid formulation of long acting insulinotropic peptide conjugate
|
|
KR101968344B1
(ko)
|
2012-07-25 |
2019-04-12 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 고지혈증 치료용 조성물
|
|
US9683044B2
(en)
|
2012-08-20 |
2017-06-20 |
Gliknik Inc. |
Molecules with antigen binding and polyvalent FC gamma receptor binding activity
|
|
EP2890402B1
(en)
|
2012-08-31 |
2019-04-17 |
Sutro Biopharma, Inc. |
Modified amino acids comprising an azido group
|
|
RU2646159C2
(ru)
|
2012-09-14 |
2018-03-01 |
Ф. Хоффманн-Ля Рош Аг |
Способ получения и отбора молекул, включающих по меньшей мере две различные группировки, и их применение
|
|
US9561275B2
(en)
|
2012-09-14 |
2017-02-07 |
The Johns Hopkins University |
Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
|
|
WO2014073842A1
(en)
|
2012-11-06 |
2014-05-15 |
Hanmi Pharm. Co., Ltd. |
Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment
|
|
KR101993393B1
(ko)
*
|
2012-11-06 |
2019-10-01 |
한미약품 주식회사 |
옥신토모듈린 유도체를 포함하는 당뇨병 또는 비만성 당뇨병 치료용 조성물
|
|
EP2943512A4
(en)
*
|
2013-01-11 |
2016-06-01 |
California Inst Biomedical Res |
BOVINE FUSION ANTIBODY
|
|
CN103217489B
(zh)
*
|
2013-01-15 |
2016-03-09 |
珠海市丽珠单抗生物技术有限公司 |
一种测定蛋白纯化工艺过程中样品的糖基化和末端修饰情况的方法
|
|
KR102073748B1
(ko)
*
|
2013-01-31 |
2020-02-05 |
한미약품 주식회사 |
재조합 효모 형질전환체 및 이를 이용하여 면역글로불린 단편을 생산하는 방법
|
|
AU2014212014A1
(en)
|
2013-02-01 |
2015-08-27 |
Amgen Inc. |
Administration of an anti-activin-A compound to a subject
|
|
JP2016511768A
(ja)
|
2013-02-22 |
2016-04-21 |
ゾエティス・サービシーズ・エルエルシー |
家禽類の成績を改善するための成長因子の卵内投与
|
|
MY186423A
(en)
*
|
2013-03-05 |
2021-07-22 |
Hanmi Pharm Ind Co Ltd |
Improved preparation method for high-yield production of physiologically active polypeptide conjugate
|
|
US20160017017A1
(en)
|
2013-03-11 |
2016-01-21 |
Novo Nordisk Healthcare Ag |
Growth Hormone Compounds
|
|
US20140271641A1
(en)
*
|
2013-03-14 |
2014-09-18 |
University Of Guelph |
Thrombospondin-1 polypeptides and methods of using same
|
|
WO2014144549A1
(en)
|
2013-03-15 |
2014-09-18 |
Biogen Idec Ma Inc. |
Factor ix polypeptide formulations
|
|
ES2708565T3
(es)
|
2013-03-15 |
2019-04-10 |
Atyr Pharma Inc |
Conjugados de Fc-histidil-ARNt sintetasa
|
|
KR101895634B1
(ko)
*
|
2013-05-31 |
2018-09-05 |
한미약품 주식회사 |
변이된 힌지 영역을 포함하는 IgG4 Fc 단편
|
|
WO2015006555A2
(en)
|
2013-07-10 |
2015-01-15 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
AR096891A1
(es)
*
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugado de monómero polipéptido biológicamente activo y conjugado de fragmento fc de inmunoglobulina, que muestra aclaramiento mediado por receptor reducido, y el método para la preparación del mismo
|
|
AR096890A1
(es)
*
|
2013-07-12 |
2016-02-03 |
Hanmi Pharm Ind Co Ltd |
Conjugando fc de inmunoglobulina, que mantiene la afinidad de unión del fragmento fc de la inmunoglobulina a fcrn
|
|
CA2918370A1
(en)
|
2013-07-18 |
2015-01-22 |
Fabrus, Inc. |
Humanized antibodies with ultralong complementarity determining regions
|
|
US9862752B2
(en)
*
|
2013-07-31 |
2018-01-09 |
Amgen Inc. |
Growth differentiation factor 15 (GDF-15) constructs
|
|
US20150093399A1
(en)
|
2013-08-28 |
2015-04-02 |
Bioasis Technologies, Inc. |
Cns-targeted conjugates having modified fc regions and methods of use thereof
|
|
WO2015035342A2
(en)
|
2013-09-08 |
2015-03-12 |
Oligasis Llc |
Factor viii zwitterionic polymer conjugates
|
|
EP3043810B1
(en)
|
2013-09-09 |
2019-10-23 |
CanImGuide Therapeutics AB |
Immune system modulators
|
|
EP3689335A1
(en)
|
2013-09-27 |
2020-08-05 |
Hanmi Pharm. Co., Ltd. |
Sustained type human growth hormone preparation
|
|
KR20160058952A
(ko)
*
|
2013-09-30 |
2016-05-25 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
에폭시화 지방 에스테르가 그 상에 배치된 섬유 및 와이프, 및 방법
|
|
WO2015070210A1
(en)
|
2013-11-11 |
2015-05-14 |
Wake Forest University Health Sciences |
Epha3 and multi-valent targeting of tumors
|
|
CR20160376A
(es)
|
2014-01-20 |
2016-10-07 |
Hanmi Pharm Ind Co Ltd |
Insulina de acción prolongada y uso de la misma
|
|
US10421796B2
(en)
*
|
2014-01-21 |
2019-09-24 |
Gray D Shaw |
Variants of IgG Fc with limited amine groups
|
|
MX387560B
(es)
*
|
2014-03-31 |
2025-03-18 |
Hanmi Pharmaceutical Co Ltd |
Procedimiento para mejorar la solubilidad de proteínas y péptidos usando un enlace del fragmento fc de inmunoglobulina.
|
|
JP6685924B2
(ja)
*
|
2014-04-11 |
2020-04-22 |
メディミューン，エルエルシー |
システイン操作抗体を含むコンジュゲート化合物
|
|
CN106536548A
(zh)
*
|
2014-04-28 |
2017-03-22 |
国家生物技术研究所公司 |
Dr3变体及其用途
|
|
KR20150133576A
(ko)
*
|
2014-05-20 |
2015-11-30 |
삼성전자주식회사 |
화학적 개질된 표적화 단백질 및 그의 이용
|
|
AR100639A1
(es)
|
2014-05-29 |
2016-10-19 |
Hanmi Pharm Ind Co Ltd |
Composición para tratar diabetes que comprende conjugados de análogos de insulina de acción prolongada y conjugados de péptidos insulinotrópicos de acción prolongada
|
|
AR100695A1
(es)
|
2014-05-30 |
2016-10-26 |
Hanmi Pharm Ind Co Ltd |
Composición para el tratamiento de diabetes mellitus que comprende insulina y un agonista dual glp-1 / glucagón
|
|
WO2015197598A2
(en)
*
|
2014-06-27 |
2015-12-30 |
Innate Pharma |
Multispecific antigen binding proteins
|
|
JP6822849B2
(ja)
|
2014-06-27 |
2021-01-27 |
イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． |
多重特異的ＮＫｐ４６結合タンパク質
|
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
|
WO2016007873A1
(en)
|
2014-07-11 |
2016-01-14 |
The Regents Of The University Of Michigan |
Compositions and methods for treating craniosynostosis
|
|
SG11201700365TA
(en)
*
|
2014-07-24 |
2017-02-27 |
Genentech Inc |
Methods of conjugating an agent to a thiol moiety in a protein that contains at least one trisulfide bond
|
|
TWI802396B
(zh)
|
2014-09-16 |
2023-05-11 |
南韓商韓美藥品股份有限公司 |
長效glp-1/高血糖素受體雙促效劑治療非酒精性脂肝疾病之用途
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
KR20210013299A
(ko)
|
2014-10-17 |
2021-02-03 |
코디악 사이언시스 인코포레이티드 |
부티릴콜린에스테라제 양성이온성 중합체 컨쥬게이트
|
|
MX389350B
(es)
|
2014-12-05 |
2025-03-19 |
Alexion Pharma Inc |
Fosfatasas alcalinas recombinantes y usos de las mismas para el tratamiento de convulsiones.
|
|
PE20171154A1
(es)
|
2014-12-30 |
2017-08-16 |
Hanmi Pharm Ind Co Ltd |
Derivados de glucagon con estabilidad mejorada
|
|
KR102418477B1
(ko)
|
2014-12-30 |
2022-07-08 |
한미약품 주식회사 |
글루카곤 유도체
|
|
JP6868561B2
(ja)
|
2015-01-28 |
2021-05-12 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
アルカリホスファターゼ欠損を有する被験者を治療する方法
|
|
WO2016144650A1
(en)
|
2015-03-06 |
2016-09-15 |
Canimguide Therapeutics Ab |
Immune system modulators and compositions
|
|
US10358476B2
(en)
|
2015-04-06 |
2019-07-23 |
Acceleron Pharma Inc. |
Single arm type I and type II receptor fusion proteins and uses thereof
|
|
CA2983440C
(en)
|
2015-04-22 |
2024-03-12 |
Alivegen Usa Inc. |
Novel hybrid actriib ligand trap proteins for treating muscle wasting diseases
|
|
JP2018518945A
(ja)
*
|
2015-04-29 |
2018-07-19 |
メディオラヌム・ファルマチェウティチ・ソチエタ・ペル・アツィオーニ |
可溶性キメラインターロイキン−１０受容体およびその療法使用
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
ES2784603T3
(es)
|
2015-06-02 |
2020-09-29 |
Novo Nordisk As |
Insulinas con extensiones recombinantes polares
|
|
US11820807B2
(en)
*
|
2015-06-12 |
2023-11-21 |
Ubi Pharma Inc |
Immunoglobulin fusion proteins and uses thereof
|
|
ES2983120T3
(es)
*
|
2015-06-12 |
2024-10-21 |
Ubi Pharma Inc |
Proteínas de fusión de inmunoglobulinas y usos de las mismas
|
|
AU2016284871B2
(en)
|
2015-06-23 |
2022-09-29 |
Innate Pharma |
Multispecific NK engager proteins
|
|
EP4523705A3
(en)
|
2015-06-30 |
2025-06-11 |
Hanmi Pharm. Co., Ltd. |
Glucagon derivative and a composition comprising a long acting conjugate of the same
|
|
US11123436B2
(en)
|
2015-07-24 |
2021-09-21 |
Hanmi Pharm. Co., Ltd. |
Method of preparing physiologically active polypeptide conjugate
|
|
KR20250053203A
(ko)
|
2015-07-24 |
2025-04-21 |
글리크닉 인코포레이티드 |
향상된 상보체 결합을 갖는 규칙적으로 다형체화된 면역글로불린 fc 조성물을 생성하기 위한 인간 단백질 단편의 융합 단백질
|
|
CN108350440A
(zh)
|
2015-08-17 |
2018-07-31 |
阿雷克森制药公司 |
碱性磷酸酯的制造
|
|
UY36870A
(es)
|
2015-08-28 |
2017-03-31 |
Hanmi Pharm Ind Co Ltd |
Análogos de insulina novedosos
|
|
WO2017053469A2
(en)
|
2015-09-21 |
2017-03-30 |
Aptevo Research And Development Llc |
Cd3 binding polypeptides
|
|
WO2017052329A1
(en)
*
|
2015-09-24 |
2017-03-30 |
Hanmi Pharm. Co., Ltd. |
Protein complex by use of a specific site of an immunoglobulin fragment for linkage
|
|
TW201718629A
(zh)
*
|
2015-09-25 |
2017-06-01 |
韓美藥品股份有限公司 |
包含多個生理多肽及免疫球蛋白Ｆｃ區之蛋白質接合物
|
|
JP6868617B2
(ja)
|
2015-09-28 |
2021-05-12 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
低ホスファターゼ血症の組織非特異的アルカリホスファターゼ（ｔｎｓａｌｐ）酵素補充療法に有効な投薬計画の特定
|
|
EP3355931B1
(en)
|
2015-10-01 |
2024-06-26 |
Novo Nordisk A/S |
Protein conjugates
|
|
JP6981973B2
(ja)
*
|
2015-10-01 |
2021-12-17 |
ヒート バイオロジクス，インコーポレイテッド |
Ｉ型及びｉｉ型細胞外ドメインを異種キメラタンパク質として連結する組成物及び方法
|
|
CN108367048B
(zh)
|
2015-10-02 |
2022-08-12 |
银溪制药股份有限公司 |
用于组织修复的双特异性治疗性蛋白质
|
|
US20170095577A1
(en)
*
|
2015-10-06 |
2017-04-06 |
Washington University |
Noninvasive imaging of focal atherosclerotic lesions using fluorescence molecular tomography
|
|
JP2018533571A
(ja)
|
2015-10-30 |
2018-11-15 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
患者の頭蓋縫合早期癒合症を治療するための方法
|
|
WO2017107914A1
(zh)
*
|
2015-12-21 |
2017-06-29 |
合肥立方制药股份有限公司 |
一种药物设计方法和获得的药物及其应用
|
|
KR20170079409A
(ko)
*
|
2015-12-30 |
2017-07-10 |
한미약품 주식회사 |
지속형 인간 성장 호르몬 결합체의 신규 액상 제제
|
|
KR20250057128A
(ko)
|
2015-12-30 |
2025-04-28 |
코디악 사이언시스 인코포레이티드 |
항체 및 이의 접합체
|
|
SG11201805586SA
(en)
|
2015-12-31 |
2018-07-30 |
Hanmi Pharmaceutical Co Ltd |
Triple glucagon/glp-1/gip receptor agonist
|
|
WO2017132615A1
(en)
|
2016-01-27 |
2017-08-03 |
Sutro Biopharma, Inc. |
Anti-cd74 antibody conjugates, compositions comprising anti-cd74 antibody conjugates and methods of using anti-cd74 antibody conjugates
|
|
AR107483A1
(es)
*
|
2016-01-29 |
2018-05-02 |
Hanmi Pharm Ind Co Ltd |
Conjugado de enzimas terapéuticas
|
|
WO2017155569A1
(en)
|
2016-03-08 |
2017-09-14 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in children
|
|
US10898549B2
(en)
|
2016-04-01 |
2021-01-26 |
Alexion Pharmaceuticals, Inc. |
Methods for treating hypophosphatasia in adolescents and adults
|
|
JP7613826B2
(ja)
|
2016-04-01 |
2025-01-15 |
アレクシオン ファーマシューティカルズ， インコーポレイテッド |
アルカリホスファターゼによって筋力低下を治療すること
|
|
JP2019515677A
(ja)
|
2016-04-26 |
2019-06-13 |
アール．ピー．シェーラー テクノロジーズ エルエルシー |
抗体複合体ならびにそれを作製および使用する方法
|
|
JP7020403B2
(ja)
|
2016-05-02 |
2022-02-16 |
味の素株式会社 |
アジド基含有Ｆｃタンパク質
|
|
CN106008722B
(zh)
*
|
2016-05-13 |
2019-10-15 |
未名生物医药有限公司 |
一种重组β-hNGF-Fc融合蛋白、制备方法及用途
|
|
US10988744B2
(en)
|
2016-06-06 |
2021-04-27 |
Alexion Pharmaceuticals, Inc. |
Method of producing alkaline phosphatase
|
|
AU2017279538A1
(en)
|
2016-06-07 |
2019-01-03 |
Gliknik Inc. |
Cysteine-optimized stradomers
|
|
EP3479841A4
(en)
|
2016-06-29 |
2020-03-04 |
Hanmi Pharm. Co., Ltd. |
GLUCAGON DERIVATIVE, CONJUGATE THEREOF, COMPOSITION THEREOF AND THERAPEUTIC USE THEREOF
|
|
EP3500289B1
(en)
|
2016-08-18 |
2024-10-09 |
Alexion Pharmaceuticals, Inc. |
Asfotase alfa for use in treating tracheobronchomalacia
|
|
RU2748402C2
(ru)
*
|
2016-08-30 |
2021-05-25 |
Дженексин,Инк. |
ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ТЕРАПИИ ДЕФИЦИТА ГОРМОНА РОСТА, СОДЕРЖАЩАЯ СЛИТЫЙ БЕЛОК hGH
|
|
JP7158378B2
(ja)
|
2016-09-23 |
2022-10-21 |
ハンミ ファーマシューティカル カンパニー リミテッド |
インスリン受容体との結合力が減少された、インスリンアナログ及びその用途
|
|
JOP20190085A1
(ar)
|
2016-10-20 |
2019-04-17 |
Biogen Ma Inc |
طرق علاج الضمور العضلي ومرض العظام باستخدام بروتينات احتجاز مركب ترابطي actriib هجين حديثة
|
|
JP2019536823A
(ja)
*
|
2016-12-05 |
2019-12-19 |
ハンミ ファーマシューティカル カンパニー リミテッド |
免疫反応が弱化された結合体
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
CN110022898B
(zh)
|
2016-12-09 |
2023-07-04 |
格利克尼克股份有限公司 |
用多价Fc化合物治疗炎性疾病的方法
|
|
MX2019006573A
(es)
|
2016-12-09 |
2019-11-18 |
Gliknik Inc |
Optimizacion de fabricacion de gl-2045 un stradomer multimerizante.
|
|
CN110545849A
(zh)
*
|
2017-02-03 |
2019-12-06 |
韩美药品株式会社 |
具有增加的持续性的生理活性物质的缀合物及其应用
|
|
US11267856B2
(en)
*
|
2017-02-27 |
2022-03-08 |
Shattuck Labs, Inc. |
CSF1R-CD40L chimeric proteins
|
|
US20190367579A1
(en)
|
2017-02-27 |
2019-12-05 |
Shattuck Labs, Inc. |
Tigit- and light-based chimeric proteins
|
|
KR102629006B1
(ko)
|
2017-03-23 |
2024-01-25 |
한미약품 주식회사 |
인슐린 수용체와의 결합력이 감소된 인슐린 아날로그의 결합체 및 이의 용도
|
|
EP3600383A4
(en)
|
2017-03-31 |
2020-10-28 |
Alexion Pharmaceuticals, Inc. |
METHODS OF TREATMENT OF HYPOPHOSPHATASIA (HPP) IN ADULTS AND ADOLESCENTS
|
|
JP2020513019A
(ja)
*
|
2017-04-05 |
2020-04-30 |
ノヴォ ノルディスク アー／エス |
オリゴマー伸長インスリン−Ｆｃコンジュゲート
|
|
CA3060514A1
(en)
|
2017-04-20 |
2018-10-25 |
Atyr Pharma, Inc. |
Compositions and methods for treating lung inflammation
|
|
JP2020517657A
(ja)
*
|
2017-04-20 |
2020-06-18 |
ノヴォ ノルディスク アー／エス |
アルブミン融合タンパク質の精製方法
|
|
CN109206522B
(zh)
*
|
2017-07-07 |
2021-11-09 |
北京三有利和泽生物科技有限公司 |
一种长效抗凝血融合蛋白及其应用
|
|
JP6566324B2
(ja)
*
|
2017-09-29 |
2019-08-28 |
サイデン化学株式会社 |
粘着シート
|
|
WO2019066603A1
(ko)
|
2017-09-29 |
2019-04-04 |
한미약품 주식회사 |
효력이 향상된 지속성 단백질 결합체
|
|
CR20200129A
(es)
|
2017-10-02 |
2020-08-22 |
Denali Therapeutics Inc |
Proteínas de fusión que comprenden enzimas de terapia de reemplazo de enzimas
|
|
KR20190045081A
(ko)
*
|
2017-10-23 |
2019-05-02 |
주식회사 프로젠 |
변형된 egf 단백질 및 이를 유효성분으로 포함하는 피부 상태 개선용 화장료 조성물
|
|
KR102167827B1
(ko)
*
|
2017-12-20 |
2020-10-20 |
주식회사 알테오젠 |
신규한 성장 호르몬 수용체 길항제 및 이의 융합 단백질
|
|
CN108218998A
(zh)
*
|
2017-12-31 |
2018-06-29 |
武汉班科生物技术股份有限公司 |
一种突变型人源IgG的Fc片段及其制备方法与应用
|
|
KR101974305B1
(ko)
*
|
2018-02-14 |
2019-04-30 |
한미사이언스 주식회사 |
생리활성 폴리펩타이드 결합체 제조 방법
|
|
EP3758737A4
(en)
|
2018-03-02 |
2022-10-12 |
Kodiak Sciences Inc. |
IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF
|
|
IL314733A
(en)
*
|
2018-03-26 |
2024-10-01 |
Regeneron Pharma |
Humanized rodents for testing therapeutic agents
|
|
KR102209108B1
(ko)
|
2018-03-27 |
2021-01-28 |
국립암센터 |
Oct4 기능 저해용 펩티드를 포함하는 줄기세포성 억제용 조성물
|
|
US11913039B2
(en)
|
2018-03-30 |
2024-02-27 |
Alexion Pharmaceuticals, Inc. |
Method for producing recombinant alkaline phosphatase
|
|
AU2019247511B2
(en)
|
2018-04-06 |
2025-10-16 |
Atyr Pharma, Inc. |
Compositions and methods comprising anti-NRP2 antibodies
|
|
CR20200510A
(es)
|
2018-04-09 |
2020-11-26 |
Amgen Inc |
Protreínas de fusión del factor de diferenciación de crecimiento 15
|
|
JP7490925B2
(ja)
|
2018-07-26 |
2024-05-28 |
エータイアー ファーマ， インコーポレイテッド |
Ｎｒｐ２関連疾患を治療するための組成物および方法
|
|
US12268733B2
(en)
|
2018-08-10 |
2025-04-08 |
Alexion Pharmaceuticals, Inc. |
Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase
|
|
US10780121B2
(en)
|
2018-08-29 |
2020-09-22 |
Shattuck Labs, Inc. |
FLT3L-based chimeric proteins
|
|
PE20220500A1
(es)
*
|
2019-04-23 |
2022-04-07 |
Lg Chemical Ltd |
POLIPEPTIDO DE FUSION QUE COMPRENDE LA REGION Fc DE INMUNOGLOBULINA Y GDF15
|
|
US11267858B2
(en)
*
|
2019-05-31 |
2022-03-08 |
Spectrum Pharmaceuticals, Inc. |
Methods of treatment using G-CSF protein complex
|
|
CN112142850A
(zh)
*
|
2019-06-27 |
2020-12-29 |
深圳市卫光生物制品股份有限公司 |
人神经生长因子-乳铁蛋白重组蛋白及用途
|
|
EP4041281B1
(en)
|
2019-10-04 |
2025-11-26 |
Amgen Inc. |
Use of gdf15 for treating cardiometabolic syndrome and other conditions
|
|
CA3157509A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
CN110669134A
(zh)
*
|
2019-10-15 |
2020-01-10 |
广东菲鹏生物有限公司 |
IgM-FC片段、IgM-FC抗体及制备方法和应用
|
|
CA3161266A1
(en)
|
2019-12-09 |
2021-06-17 |
Alexion Pharmaceuticals, Inc. |
Alkaline phosphatase polypeptides and methods of use thereof
|
|
CA3159979A1
(en)
*
|
2019-12-11 |
2021-06-17 |
Yeonchul Kim |
Fusion polypeptide comprising gdf15 and polypeptide region capable of o-glycosylation
|
|
CN111153996B
(zh)
*
|
2020-01-10 |
2021-12-14 |
苏州睿瀛生物技术有限公司 |
G蛋白偶联受体的抗体及其制备方法和g蛋白偶联受体试剂盒
|
|
CN111505291B
(zh)
*
|
2020-04-14 |
2023-04-25 |
山东省千佛山医院 |
一种排除巨酶分子对血清酶浓度检测带来干扰的方法
|
|
WO2021235915A1
(ko)
|
2020-05-22 |
2021-11-25 |
한미약품 주식회사 |
액상 제제
|
|
AU2021337652B2
(en)
|
2020-09-04 |
2025-01-30 |
Alexion Pharmaceuticals, Inc. |
Methods for treating bone mineralization disorders
|
|
CN112098639B
(zh)
*
|
2020-09-21 |
2024-01-02 |
天津医科大学 |
以氧化石墨烯为载体的二抗的合成及应用
|
|
MX2023005235A
(es)
*
|
2020-11-03 |
2023-10-16 |
Protalix Ltd |
Uricasa modificada y usos de la misma.
|
|
BR112023016048A2
(pt)
|
2021-02-12 |
2023-11-14 |
Alexion Pharma Inc |
Polipeptídeos de fosfatase alcalina e métodos de uso dos mesmos
|
|
MX2024002611A
(es)
|
2021-08-30 |
2024-05-29 |
Lassen Therapeutics 1 Inc |
Anticuerpos anti-il-11ra.
|
|
WO2023147489A2
(en)
*
|
2022-01-28 |
2023-08-03 |
argenx BV |
Anti-musk antibodies for use in treating neuromuscular disorders
|
|
IL315251A
(en)
*
|
2022-03-03 |
2024-10-01 |
Univ Pennsylvania |
Viral vectors encoding parathyroid hormone fusions and their uses for the treatment of hypoparathyroidism
|
|
CN114588315A
(zh)
*
|
2022-03-14 |
2022-06-07 |
东莞市人民医院 |
抗炎蛋白涂层的制备方法、生物工程功能材料及其应用
|
|
CN120435493A
(zh)
*
|
2022-12-05 |
2025-08-05 |
阿雷克森制药公司 |
用于多功能抑制baff、april和新生儿fc受体的taci-fc融合蛋白
|
|
CN120787238A
(zh)
|
2023-01-06 |
2025-10-14 |
拉森医疗公司 |
用于治疗甲状腺眼病的抗IL-11Rα抗体
|
|
KR20250133728A
(ko)
|
2023-01-06 |
2025-09-08 |
라센 테라퓨틱스, 인코포레이티드 |
항-il-18bp 항체
|
|
TW202430560A
(zh)
|
2023-01-06 |
2024-08-01 |
美商拉森醫療公司 |
抗ｉｌ－１８ｂｐ抗體
|